ASHLI MULLINS: Open Payments
NPI 1427525377 · HAZARD, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 39 payments from 13 companies in 2025. Trend: 2023 $674 · 2024 $637 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 9 | $178 |
| Vanda Pharmaceuticals Inc. | 10 | $145 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $86 |
| ABBVIE INC. | 3 | $57 |
| Lundbeck LLC | 3 | $55 |
| Alkermes, Inc. | 2 | $40 |
| E.R. Squibb & Sons, L.L.C. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Teva Pharmaceuticals USA, Inc. | 1 | $19 |
| Ardelyx, Inc. | 1 | $16 |
Products named: HETLIOZ, SPRAVATO, CAPLYTA, INVEGA SUSTENNA, VRAYLAR, REXULTI, ARISTADA, COBENFY.
Industry payments across KY — which companies pay providers there.
